1. AB0364 A Novel Approach for Rheumatoid Arthritis: Results of The Ongoing Clinical Trials with The Fully Human Immunocytokine Dekavil (F8-IL10). (15th July 2016) Authors: Galeazzi, M.; Voll, R.; Sebastiani, G.; Bazzichi, L.; Viapiana, O.; Dudler, J.; Sarzi-Puttini, P.; Selvi, E.; Iuliano, A.; Pedretti, M.; Giovannoni, L.; Bindi, I.; Bettini, C.; Ravenni, N.; Wilton, J.; Zufferey, P.; Ferraccioli, G.; Caporali, R.; Specker, C.; Wollenhaupt, J. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 1028 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0371 Is Switching from IV To SC Abatacept Therapy Sustainable in The Real World? 1-Year Analysis of The Prospective, International Action Study. (15th July 2016) Authors: Alten, R.; Nüßlein, H.; Galeazzi, M.; Lorenz, H.M.; Mariette, X.; Cantagrel, A.; Chartier, M.; Elbez, Y.; Rauch, C.; Le Bars, M. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 1030 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0453 Do Changes in Clinical Practice Over Time in Europe and Canada Have an Impact on Baseline Characteristics of Patients Initiating Intravenous Abatacept in the Action Study?. (9th June 2015) Authors: Nüβlein, H.; Alten, R.; Galeazzi, M.; Lorenz, H.-M.; Cantagrel, A.; Chartier, M.; Poncet, C.; Rauch, C.; Le Bars, M. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1047 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0465 Etanercept therapy in rheumatoid arthritis patients with moderate or severe disease activity. (23rd January 2014) Authors: Iannone, F.; Ferraccioli, G.; Ferri, C.; Galeazzi, M.; Gerli, R.; Giacomelli, R.; Grassi, W.; Gorla, R.; Govoni, M.; Marchesoni, A.; Punzi, L.; Sarzi-Puttini, P.; Triolo, G.; Lapadula, G. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 664 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AB0477 Retention Rates and Clinical Outcomes in Cohorts of Patients (Biologic Naïve or Failed Prior Biologics) Treated with Intravenous Abatacept in a Real-World Setting: 6-Month Results from the Action Study. (9th June 2015) Authors: Alten, R.; Nüßlein, H.; Galeazzi, M.; Lorenz, H.-M.; Mariette, X.; Cantagrel, A.; Chartier, M.; Poncet, C.; Rauch, C.; Le Bars, M. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1056 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. AB0531 Real-world efficacy and safety of abatacept treatment for RA: 12-month interim analysis of the action study. (23rd January 2014) Authors: Nüßlein, H.; Alten, R.; Galeazzi, M.; Lorenz, H.M.; Boumpas, D.; Nurmohamed, M.T.; Bensen, W.G.; Burmester, G.R.; Peter, H.H.; Rainer, F.; Pavelka, K.; Chartier, M.; Poncet, C.; Rauch, C.; Le Bars, M. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 668 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. AB0532 Effect of prior therapy on the efficacy and safety of abatacept: 6-month analysis of the action study. (23rd January 2014) Authors: Nüßlein, H.; Alten, R.; Galeazzi, M.; Lorenz, H.M.; Boumpas, D.; Nurmohamed, M.T.; Bensen, W.G.; Burmester, G.R.; Peter, H.H.; Rainer, F.; Pavelka, K.; Chartier, M.; Poncet, C.; Rauch, C.; Le Bars, M. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 668 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. AB0535 Effects of tocilizumab on bone density and metabolism in patients with active rheumatoid arthritis. (23rd January 2014) Authors: Pierguidi, S.; Bertoldi, I.; Adinolfi, A.; Filippou, G.; Picerno, V.; Galeazzi, M.; Frediani, B. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 668 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. AB0681 COMPARISON BETWEEN DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF PREDOMINANT AXIAL VS MAINLY PERIPHERAL SPONDYLOARTHRITIS (SpA) PATIENTS, ENROLLED IN THE ONGOING SIRENA STUDY. (2nd June 2020) Authors: Foti, R.; Cardinale, G.; Costa, L.; Franceschini, F.; Ciccia, F.; Marchesoni, A.; Guggino, G.; Rossini, M.; Lubrano, E.; Galeazzi, M.; Chimenti, M.; Bianchi, G.; Galfo, G.; Marelli, S.; Favalli, E. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1636 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. AB0709 Switching from originator infliximab to biosimilar infliximab: efficacy and safety in a cohort of patients with established behÇet's disease. (12th June 2018) Authors: Venerito, V.; Lopalco, G.; Cantarini, L.; Fabiani, C.; Nivuori, M.; Cacciapaglia, F.; Galeazzi, M.; Lapadula, G.; Iannone, F. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1494 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗